Zivo Bioscience, Inc. (ZIVO): Total Liabilities

Annual figures by period end, from SEC filings.

Not updated since 2024-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2017-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$2.16M
As of 2024-12-31
$3.85M
As of 2025-09-30
-9.9%
3-year compound annual growth
-24.3%
5-year compound annual growth
$22.69M2010-12-31: $1.29M2011-12-31: $2.49M2012-12-31: $4.19M2013-12-31: $11.77M2014-12-31: $6.47M2015-12-31: $9.57M2016-12-31: $14.36M2017-12-31: $16.64M2018-12-31: $22.69M2019-12-31: $8.71M2020-12-31: $11.53M2021-12-31: $2.95M2022-12-31: $2.13M2023-12-31: $2.76M2024-12-31: $2.16M$2.16M
2010-12-31 Total Liabilities (USD) 2024-12-31
Period endedTotal LiabilitiesChange YoYSource filing
2024-12-31$2.16M-21.9%2025-03-18, Balance as of period end
2023-12-31$2.76M+29.4%2025-03-18, Balance as of period end
2022-12-31$2.13M-27.6%2024-03-15, Balance as of period end
2021-12-31$2.95M-74.4%2023-03-14, Balance as of period end
2020-12-31$11.53M+32.4%2022-04-22, Balance as of period end
2019-12-31$8.71M-61.6%2021-02-25, Balance as of period end
2018-12-31$22.69M+36.4%2020-03-26, Balance as of period end
2017-12-31$16.64Mn/c2019-02-12, Balance as of period end
2016-12-31$14.36M+50.0%2018-02-21, Balance as of period end
2015-12-31$9.57M+47.9%2017-03-31, Balance as of period end
2014-12-31$6.47M-45.0%2016-03-29, Balance as of period end
2013-12-31$11.77M+180.9%2015-04-06, Balance as of period end
2012-12-31$4.19M+67.9%2014-03-31, Balance as of period end
2011-12-31$2.49M+93.2%2013-03-25, Balance as of period end
2010-12-31$1.29Mn/a2012-03-30, Balance as of period end